Quality of life and comorbid anxiety disorder in persons with schizophrenia, schizo-affective and bipolar affective disorder under remission

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2015, Vol 5, Issue 8

Abstract

 BACKGROUND: Quality of life is considered in clinical psychiatry as an intermediate and distal outcome in the management of major mental disorders. Anxiety disorder is the commonest mental disorder which can be identified easily and can be treated easily. Treating co-morbid Anxiety disorders has multiple benefits of improving quality of life, reducing distress to the patient and family, and performance of the patient. AIM: To assess the quality of life and comorbid anxiety disorder in persons with schizophrenia, schizoaffective and bipolar affective disorder under remission. METHODS: Patients attending for review at Institute of Mental Health (IMH), Hyderabad, diagnosed with schizophrenia, schizoaffective disorder and bipolar affective disorder according to ICD-10 in the past and currently on treatment were all considered. Tools administered included - Mini international neuropsychiatric interview (MINI) to ascertain any other axis I diagnosis; Hamilton anxiety rating scale (HAM–A) to know the severity of anxiety symptoms and WHO QOL – BREF for assessing the quality of life RESULTS : The mean physical health, psychological, social, and environmental domain of WHOQOL-BREF scale scores in schizophrenia, bipolar group and schizoaffective groups were found to be significant. HAM-A mean scores of schizophrenia group, bipolar group and schizoaffective group were 7.23, 7.83 & 5.23 respectively. CONCLUSION In the present study sample, Schizophrenia group scored the highest on WHOQOL-BREF scale while bipolar scored the least. However there was no significant difference among three groups when compared. The most commonly reported anxiety symptoms on HAM-A scale was anxious mood and cardiovascular symptoms. There was no significant difference of anxiety levels among the three groups. In future, studies must be carried out on patients under remission over a period of time, preferably from a sample in the community

Authors and Affiliations

Dr. Vivaswan Boorla* , Dr. Siva Prasad Kasimahanti M. D (Psy)

Keywords

Related Articles

 Cervical Sympathetic chain ganglioneuroma : case report and review of literature

 Ganglioneuroms are benign tumor of the autonomic nerve fibers, arising from neural crest and the reported incidence of ganglioneuroma is one per million population. They usually present in patients under 20 y...

Medicinal Plants Used in Complementary Medicinal for the Treatment of Burns in Rutshuru Territory (North-Kivu, Democratic Republic of Congo).

Background: Burns are a common problem in the Democratic Republic of Congo and other many countries in the world. It management poses a difficult challenge. The purpose of this study was to investigate medicinal plants u...

 Ethnobotanical Survey of Medicinal Plants Used By the Traditional Medical Healers in the Villages of Bérégadougou and Fabédougou (Cascades Region, Burkina Faso).

 Bacground:An ethnobotanical study carried out in two localities of Cascades Region (Bérégadougou and Fabédougou) and aimed to collect data on medicinal plants (MP) from the traditional medical practitioners and to...

Download PDF file
  • EP ID EP148371
  • DOI -
  • Views 67
  • Downloads 0

How To Cite

Dr. Vivaswan Boorla*, Dr. Siva Prasad Kasimahanti M. D (Psy) (2015).  Quality of life and comorbid anxiety disorder in persons with schizophrenia, schizo-affective and bipolar affective disorder under remission. IOSR Journal of Pharmacy (IOSRPHR), 5(8), 23-30. https://europub.co.uk/articles/-A-148371